NEW YORK, May 21, 2026, 09:11 (EDT)
- Aterian was quoted at $1.15 in premarket trade, down 2.5% from Wednesday’s close.
- The company is seeking stockholder approval for a $18 million brand sale and a $7 million preferred-stock investment.
- A May 15 filing showed a wider first-quarter loss and warned of “substantial doubt” about Aterian’s ability to continue as a going concern.
Aterian Inc. shares edged lower before the U.S. open on Thursday, with investors still pricing a proposed asset sale and financing package that would sharply reshape the consumer-products company. The stock was quoted at $1.15 in premarket trading, down 2.5% from its previous close, before Nasdaq’s 9:30 a.m. ET regular session.
That is the story now: not a new product launch, not a fresh earnings call, but a small-cap company trying to get holders behind a transaction that could sell its main brands and shift control. Aterian’s market value was about $12.8 million, according to current market data.
The shares closed at $1.18 on Wednesday after trading between $1.12 and $1.20 on volume of about 312,000 shares, Yahoo Finance historical data showed. The stock had closed at $1.22 on Tuesday.
Aterian said on April 28 it had agreed to sell assets tied to Mueller Living, PurSteam, hOmeLabs, Squatty Potty, Healing Solutions and Photo Paper Direct to Trademark Global for $18 million in cash, subject to adjustments. The board approved the deal, but stockholders still have to vote; Aterian said it expected to keep smaller legacy brands such as Vremi and Xtava.
Chief Executive Arturo Rodriguez called the deal a “strong outcome for investors” and said the brands would get a chance to grow under an experienced e-commerce supplier. Bill Kurtz, Aterian’s board chair, said the company wanted a “smooth transition” as David E. Lazar joined the board and prepared to take a larger role.
The second leg is the financing. Lazar agreed to buy $7 million of convertible preferred stock — preferred shares that can convert into common stock — in two tranches of $3.5 million each. The first tranche closed on April 27, and the second is expected after stockholder approval.
The April 29 filing said that, after the second closing, Lazar would hold about 95.13% of Aterian’s fully diluted capitalization, while existing equityholders would hold about 4.87%. Fully diluted means the share count after including securities that can convert into common shares. Aterian also agreed to seek a special meeting no later than July 20, with proposals including a share issuance to Lazar, an increase in authorized shares and a reverse split in a range from 1-for-2 to 1-for-99.
The preliminary proxy filed May 15 asks holders to approve the sale of substantially all assets, the preferred-stock conversion under Nasdaq rules, the reverse split and an increase in authorized common shares to as many as 1 billion. The proxy form had not filled in a final meeting date or time.
The latest quarterly filing shows why the stock is trading more like a restructuring name than a normal consumer-products story. For the first quarter, Aterian reported a net loss of $6.1 million, wider than $3.9 million a year earlier; discontinued operations tied to the assets marked for sale generated $12.4 million of revenue, down 18.8%, and the company booked a $3.4 million non-cash impairment charge. Aterian also said management had determined there was “substantial doubt” about its ability to continue as a going concern, a warning that a company may not have enough resources to keep operating without financing, asset sales or other changes. Aterian
The competitive backdrop is not soft. Aterian’s brands sell mainly through online channels such as Amazon, Walmart and Target, where smaller consumer-products companies often fight for search placement, advertising return and logistics efficiency. Trademark Global, the proposed buyer, is a privately held e-commerce operator that Aterian described as owning or managing more than 20 consumer brands.
But the deal is not done. Aterian said closing depends on stockholder approval and other conditions, including contribution-margin thresholds, and warned that the pending sale and leadership transition could hurt employee retention. If the vote fails, the asset sale stalls or the preferred conversion goes through on terms investors dislike, the downside is plain: more dilution, less liquidity, and a company still dealing with losses and Nasdaq-listing risk.
